Zydus Lifesciences

quarterly
yearly
ParticularsDec '23Mar '24Jun '24Sep '24Dec '24
Revenue2,4783,6944,2672,9472,593
Expenses1,9042,0002,0331,9082,096
EBITDA805.901,9302,4801,269726.00
EBIT678.201,7912,3491,135594.40
Profit Before Tax574.301,6852,2341,039497.20
Net Profit450.401,4051,701789.80470.60
Financial Ratios
Operating Profit Margin36.22%60.57%61.44%50.51%30.14%
Net Profit Margin20.24%44.50%42.15%31.44%19.54%
Earning Per Share (Diluted)4.4513.8916.907.854.68
Dividends Per Share0.000.000.000.000.00
ⓒ 2016-2025 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 5.7.3
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ